Misdiagnosis of Multiple Sclerosis Remains Common, Experts Say
Doctors explain that the lack of a definitive test and vague early symptoms lead to frequent multiple sclerosis misdiagnoses, as highlighted by actress Christina Applegate’s recent reversal of her diagnosis.
Actress Christina Applegate, who publicly disclosed a multiple sclerosis (MS) diagnosis in 2021, announced this week that she has been re-evaluated and does not have the disease, leaving her doctors still searching for the cause of her debilitating symptoms. The reversal underscores a broader issue: studies estimate that about 15 % of MS diagnoses in the United States may be false positives.
Multiple sclerosis is an autoimmune disorder that damages the protective covering of nerve fibers in the brain and spinal cord, producing symptoms such as motor impairment, tingling, vision problems, fatigue and cognitive fog. Because the condition’s early signs are often nonspecific and because no single test can definitively confirm MS, diagnosis relies on a combination of magnetic resonance imaging (MRI), spinal fluid analysis and clinical assessment. MRI findings can be ambiguous, and other rare neurological or vascular conditions sometimes mimic the lesions associated with MS.
“Neurological symptoms sometimes can be vague — numbness, pins and needles — and it’s usually short-lived,” said Dr. Saud Sadiq, chief research scientist at the Tisch Multiple Sclerosis Research Center.
“Because it’s so heterogeneous, it doesn’t present in the same way in everybody and can have varying severity, it can be hard to diagnose sometimes,” added Dr. Andrew Solomon, a neurologist at the University of Vermont.
Researchers note that pressure to initiate treatment quickly may encourage some clinicians to label uncertain cases as MS, especially given the availability of disease-modifying therapies that are most effective when started early. A 2025 study led by Solomon found that 40 % of patients later confirmed to have MS were initially misdiagnosed with another condition.
The National Multiple Sclerosis Society introduced updated diagnostic criteria in 2024, and experts anticipate that artificial-intelligence tools could improve MRI interpretation. Specialists advise patients to seek evaluation at recognized MS centers, request thorough review of imaging by experts, and consider a spinal fluid test despite insurance hurdles. They also recommend obtaining a second opinion when a serious diagnosis is made.
“My message to patients is: Listen, just get the spinal. This way we’ll be sure,” said Dr. Annette Langer-Gould of Kaiser Permanente.
While proper diagnosis can lead to effective long-term management—new drugs have markedly improved prognosis—patients are urged to monitor persistent symptoms such as numbness lasting more than 24-48 hours, unilateral vision changes, or unexplained motor weakness, and to discuss the specific diagnostic criteria with their physicians.